Market Research Industry Reports

Regenicin Inc (RGIN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

Regenicin Inc (Regenicin), formerly Windstar Inc is a biotechnology company that develops regenerative cell therapies. The company offers NovaDerm, a tissue-engineered skin prepared from autologous skin cells. Its NovaDerm technology uses the patients own skin cells to generate living, tissue-engineered skin for the treatment of severe burns. Regenicin offers banked allogenic cell products for treatment of chronic wounds, cosmetic and other topical testing, and medical testing services. The company develops products for diabetes and chronic wounds including ulcers, adult stem cell therapies and reconstructive surgical applications. It has operations throughout the US. Regenicin is headquartered in Little Falls, New Jersey, the US.

Regenicin Inc (RGIN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

It derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief Summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a Summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.



List of Tables 4
List of Figures 4
Regenicin Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Regenicin Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Regenicin Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Regenicin Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Regenicin Inc, Medical Devices Deals, 2012 to YTD 2018 9
Regenicin Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Regenicin Inc, Pharmaceuticals & Healthcare, Deal Details 11
Debt Offering 11
Regenicin Raises USD0.1 Million in Private Placement of 8% Note Due May 2014 11
Regenicin Raises USD0.3 Million in Private Placement of 8% Notes Due 2014 12
Regenicin Raises Funds through Private Placement of 8% Note Due November 2013 13
Regenicin Raises USD0.1 Million in Private Placement of 10% Note Due June 2013 14
Regenicin Raises USD0.1 Million in Private Placement of 10% Note Due January 2013 15
Regenicin Raises Funds through Private Placement of 33% Note Due October 2012 16
Regenicin Raises USD0.2 Million in Private Placement of 33% Note Due November 2012 17
Regenicin Raises USD0.2 Million in Private Placement of 33% Note Due 2012 18
Regenicin Raises USD0.1 Million in Private Placement of 8% Note Due March 2012 19
Regenicin Raises USD0.16 Million in Private Placement of 5% Note Due June 2012 20
Regenicin Inc - Key Competitors 21
Regenicin Inc - Key Employees 22
Regenicin Inc - Locations And Subsidiaries 23
Head Office 23
Other Locations & Subsidiaries 23
Recent Developments 24
Financial Announcements 24
Jan 18, 2017: Regenicin Reports 2016 Operating Results, Outlines Milestones for 2017 24
Appendix 25
Methodology 25
About GlobalData 25
Contact Us 25
Disclaimer 25

List Of Tables


Regenicin Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Regenicin Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Regenicin Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Regenicin Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Regenicin Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Regenicin Inc, Medical Devices Deals, 2012 to YTD 2018 9
Regenicin Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 10
Regenicin Raises USD0.1 Million in Private Placement of 8% Note Due May 2014 11
Regenicin Raises USD0.3 Million in Private Placement of 8% Notes Due 2014 12
Regenicin Raises Funds through Private Placement of 8% Note Due November 2013 13
Regenicin Raises USD0.1 Million in Private Placement of 10% Note Due June 2013 14
Regenicin Raises USD0.1 Million in Private Placement of 10% Note Due January 2013 15
Regenicin Raises Funds through Private Placement of 33% Note Due October 2012 16
Regenicin Raises USD0.2 Million in Private Placement of 33% Note Due November 2012 17
Regenicin Raises USD0.2 Million in Private Placement of 33% Note Due 2012 18
Regenicin Raises USD0.1 Million in Private Placement of 8% Note Due March 2012 19
Regenicin Raises USD0.16 Million in Private Placement of 5% Note Due June 2012 20
Regenicin Inc, Key Competitors 21
Regenicin Inc, Key Employees 22
Regenicin Inc, Subsidiaries 23

List Of Figures


Regenicin Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Regenicin Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Regenicin Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Regenicin Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Regenicin Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Regenicin Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Regenicin Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Regenicin Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Regenicin Inc, Medical Devices Deals, 2012 to YTD 2018 9

Regenicin Inc (RGIN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Regenicin Inc (Regenicin), formerly Windstar Inc is a biotechnology company that develops regenerative cell therapies. The company offers NovaDerm, a tissue-engineered skin prepared from autologous skin cells. Its NovaDerm technology

USD 250View Report

regenicin inc (rgin) - medical equipment - deals and alliances profile

Regenicin Inc (Regenicin), formerly Windstar Inc is a biotechnology company that develops regenerative cell therapies. The company offers NovaDerm, a tissue-engineered skin prepared from autologous skin cells. Its NovaDerm technology

USD 250View Report

regenicin inc (rgin) - medical equipment - deals and alliances profile

Regenicin Inc (Regenicin), formerly Windstar Inc is a biotechnology company that develops regenerative cell therapies. The company offers NovaDerm, a tissue-engineered skin prepared from autologous skin cells. Its NovaDerm technology

USD 250View Report

Regenicin Inc (RGIN) - Financial and Strategic SWOT Analysis Review

Regenicin Inc (Regenicin), formerly Windstar Inc is a biotechnology company that develops regenerative cell therapies. The companys products include PermaDerm and banked allogenic cell products. It offers NovaDerm, a tissue-engineered

USD 300View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Jul 2018
No. of Pages :25
Country :United States of America
Category :Company Profiles
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube